Delayed gastric emptying: Whom to test, how to test, and what to do

Soykan I, Sivri B, Sarosiek I, et al.: Demography, clinical characteristics, psychological profiles, treatment and long-term follow-up of patients with gastroparesis. Dig Dis Sci 1998, 43:2398–2404.

Frank JW, Saslow SB, Camilleri M, et al.: Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology 1995, 109:755–765.

Kong MF, Horowitz M, Jones KL, et al.: Natural history of diabetic gastroparesis. Diabetes Care 1998, 22:503–507.

He CL, Soffer EE, Ferris CD, et al.: Loss of interstitial cells of Cajal and inhibitory innervation in insulindependent diabetes. Gastroenterology 2001, 121:427–434.

Sarnelli G, Caenepeel P, Geypens B, et al.: Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003, 98:783–788.

Jebbink RJA, Samsom M, Bruijs PPM, et al.: Hyperglycemia induces abnormalities of gastric myoelectrical activity in patients with type 1 diabetes mellitus. Gastroenterology 1994, 107:1390–1397.

Hasler WL, Soudah HC, Dulai G, Owyang C: Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins. Gastroenterology 1995, 108:727–736.

Lemann M, Dederding JP, Flourie B, et al.: Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. Dig Dis Sci 1991, 36:1249–1254.

Hoogerwerf WA, Pasricha PJ, Kalloo AN, Schuster MM: Pain: the overlooked symptom in gastroparesis. Am J Gastroenterol 1999, 94:1029–1033.

Kim DY, Myung SJ, Camilleri M: Novel testing of human gastric motor and sensory functions: rationale, methods, and potential applications in clinical practice. Am J Gastroenterol 2000, 95:3365–3373.

Guo JP, Maurer AH, Fisher RS, Parkman HP: Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis. Dig Dis Sci 2001, 46:24–29.

Datz FL, Christian PE, Moore J: Gender-related differences in gastric emptying. J Nucl Med 1987, 28:1204–1207.

Parkman HP, Schwartz SS: Esophagitis and other gastrointestinal disorders associated with diabetic gastroparesis. Arch Intern Med 1987, 147:1477–1480.

Parkman HP, Harris AD, Krevsky B, et al.: Gastroduodenal motility and dysmotility: update on techniques available for evaluation. Am J Gastroenterol 1995, 90:869–892.

Thomforde GM, Camilleri M, Phillips SF, Forstrom LA: Evaluation of an inexpensive screening scintigraphic test of gastric emptying. J Nucl Med 1995, 36:93–96.

Choi MG, Camilleri M, Burton DD, et al.: Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol 1998, 93:92–98.

Bromer MQ, Kantor SB, Wagner DA, et al.: Simultaneous measurement of gastric emptying with a simple muffin meal using [13C] octanoate breath test and scintigraphy in normal subjects and patients with dyspeptic symptoms. Dig Dis Sci 2002, 47:1657–1663.

Ghoos YF, Maes BD, Geypens BJ, et al.: Measurement of gastric emptying rate of solids by means of a carbonlabeled octanoic acid breath test. Gastroenterology 1993, 104:1640–1647.

Soffer E, Thongsawat S: Clinical value of duodenojejunal manometry. Its usefulness in diagnosis and management of patients with gastrointestinal symptoms. Dig Dis Sci 1996, 41:859–863.

Mearin F, Camilleri M, Malagelada JR: Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986, 90:1919–1925.

Camilleri M, Brown ML, Malagelada JR: Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology 1986, 91:94–99.

Friedenberg FK, Parkman HP: Management of delayed gastric emptying. Clin Gastroenterol Hepatol 2005, 3:642–646. Recent review of clinical management of a patient with diabetic gastroparesis that provides an algorithm for treatment.

Lehmann R, Honegger RA, Feinle C, et al.: Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. A pilot study with cisapride as a model drug. Exp Clin Endocrinol Diabetes 2003, 111:255–261.

Petiakis IE, Vrachassotakis N, Sciacca V, et al.: Hyperglycemia attenuates erythromycin-induced acceleration of solid phase gastric emptying in idiopathic and diabetic gastroparesis. Scand J Gastroenterol 1999, 34:396–403.

Brownlee M, Kroopf SS: Metoclopramide for gastroparesis diabeticorum. N Engl J Med 1974, 291:1257–1258.

Perkel MS, Moore C, Hersh T, Davidson ED: Metoclopramide therapy in patients with delayed gastric emptying. Dig Dis Sci 1979, 24:662–666.

McCallum RW, Ricci DA, Rakatansky H, et al.: A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care 1983, 6:463–467.

Ganzini L, Casey DE, Hoffman WF, McCall AL: The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med 1993, 153:1469–1475.

Miller LG, Jankovic J: Metoclopramide-induced movement disorders. Clinical findings with a review of the literature. Arch Intern Med 1989, 149:2486–2492.

Lata PF, Pigarelli DL: Chronic metoclopramide therapy for diabetic gastroparesis. Ann Pharmacother 2003, 37:122–126.

Peeters TL: Erythromycin and other macrolides as prokinetic agents. Gastroenterology 1993, 105:1886–1899.

Patterson D, Abell T, Rothstein R, et al.: A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol 1999, 94:1230–1234.

Watts GF, Armitage M, Sinclair J, Hill JD: Treatment of diabetic gastroparesis with oral domperidone. Diabetic Med 1985, 2:491–492.

Jones MP: Access options for withdrawn motility-modifying agents. Am J Gastroenterol 2002, 97:2184–2188.

DiBaise JK, Quigley EMM: Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis. J Clin Gastroenterol 1999, 28:131–134.

Maganti K, Onyemere K, Jones MP: Oral erythromycin and symptomatic relief of gastroparesis: a systematic review. Am J Gastroenterol 2003, 98:259–263.

Erbas T, Varoglu E, Erbas B, et al.: Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis. Diabetes Care 1993, 16:1511–1514.

Di Stefano M, Vos R, Janssens J, Tack JF: Effect of tegaserod, a 5-HT4 receptor partial agonist, on interdigestive and postprandial gastrointestinal motility in healthy volunteers [abstract]. Gastroenterology 2003, 124:A163.

Degen L, Matzinger D, Merz M, et al.: Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther 2001, 15:1745–1751.

Tougas G, Chen Y, Luo D, et al.: Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms [abstract]. Gastroenterology 2003, 124:A54-A68.

Bromer MQ, Friedenberg F, Miller LS, et al.: Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 2005, 61:833–839.

Miller LS, Szych GA, Kantor SB, et al.: Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol 2002, 97:1653–1660.

Friedenberg F, Gollamudi S, Parkman HP: Review: the use of botulinum toxin for the treatment of gastrointestinal motility disorders. Dig Dis Sci 2004, 2:165–175. A thorough review of the GI uses of botulinum toxin.

Hotokezaka M, Adams RB, Miller AD, et al.: Laparoscopic percutaneous jejunostomy for long term enteral access. Surg Endosc 1996, 10:1008–1011.

Abell T, McCallum R, Hocking M, et al.: Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003, 125:421–428. The largest controlled trial to date on the use of the gastric stimulator.